A new collaborative publication from the Wallrath Laboratory was published this week!  

"A genetics variant in SMAD7 acts as a modifier of LMNA-associated muscular dystrophy, implicating SMAD signaling as a therapeutic target." 

N Mohar, C Langland, Z Darr, J Viles, S Moore, B Darbro, and L Wallrath. 

Science Advances, 11(16), eads7903, (2025)